BioSpace News Archive

SRI Biosciences has been awarded a $14.7 million contract sponsored by the Defense Threat Reduction Agency through the Medical, Chemical, Biological, Radiological, and Nuclear Defense Consortium to continue development of a high-concentration naloxone product for intravenous, intramuscular and subcutaneous injection, or intravenous infusion.

Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) (the “Company” or “Inspira Technologies”), announced today it has filed a Patent Cooperation Treaty (PCT) patent application for its novel ART device and its proprietary methods of use to minimize the need for invasive mechanical ventilation which requires intubation and induced coma.

ZymoChem, Inc., an early-stage bioproducts company engineering microbial-based processes for manufacturing industrial chemicals and crafting high-performance materials, today announced that it has closed a $4 million Seed financing.

RSIP Vision, an experienced leader in driving innovation for medical imaging through advanced AI and computer vision solutions, today announces a new coronary artery modelling technology.

Innovia Medical (“Innovia”) is thrilled to announce the expansion of their single-use instrument product line into the U.S.

Herophilus today announced that the company is expanding its scientific advisory board with the appointment of Kenneth S. Kosik, M.A., M.D.

Essence Group today announced it will showcase the world’s first 5G-enabled mobile personal emergency response system (mPERS) at CES 2022 in January.

PharmaCyte Biotech, Inc. announced today the results of an additional, more detailed, analysis of the integration site of the cytochrome P450 2B1 gene from the augmented HEK293 cell clone that PharmaCyte uses in its CypCap™ product.

Pulmotect reported positive results from their second randomized, placebo-controlled Phase-2 trial of PUL-042 against COVID-19.

Nordic Nanovector announces that its CEO, Erik Skullerud will present a corporate overview via live webcast at DNB’s 12th Nordic Healthcare Conference on 16 December 2021.